pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 322 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    fruquintinib
    Fruzaqla (fruquintinib)
    Metastatic Colorectal Cancer Takeda Pharmaceuticals USA Inc1 cat
  • Marketed
    zanubrutinib
    Brukinsa (zanubrutinib)
    Membranous Glomerulonephritis$ONC BeOne Medicines Ltd.1 cat
  • Marketed
    lenvatinib mesylate
    Lenvima (lenvatinib mesylate)
    Renal Cell Carcinoma Eisai Co Ltd2 cat
  • Marketed
← prev
page 2 of 11
next →
131
Pain89
Neurology1
eflornithine hydrochloride
Iwilfin (eflornithine hydrochloride)
Neuroblastoma
US WorldMeds LLC
1 cat
  • Marketed
    inavolisib
    Itovebi (inavolisib)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… F. Hoffmann-La Roche Ltd3 cat
  • Marketed
    imetelstat sodium
    Rytelo (imetelstat sodium)
    Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)$GERN GERON CORP2 cat
  • Marketed
    quizartinib dihydrochloride
    Vanflyta (quizartinib dihydrochloride)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Daiichi Sankyo Co Ltd3 cat
  • Marketed
    METHYLPREDNISOLONE ACETATE
    METHYLPREDNISOLONE ACETATE
    Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti… Hong Kong King-Friend Pharmaceutical Co Ltd41 cat
  • Marketed
    lutetium Lu 177 vipivotide tetraxetan
    Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
    Hormone-Sensitive Prostate Cancer$NVS NOVARTIS AG4 cat
  • Marketed
    (berahyaluronidase alfa + pembrolizumab)
    Keytruda Qlex ((berahyaluronidase alfa-pmph + pembrolizumab))
    Muscle Invasive Bladder Cancer (MIBC)$MRK Merck & Co., Inc.5 cat
  • Marketed
    epcoritamab
    Epkinly (epcoritamab-bsyp)
    Diffuse Large B-Cell Lymphoma Genmab AS5 cat
  • Marketed
    niraparib
    Zejula (niraparib)
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON5 cat
  • Marketed
    Spexotras
    Mekinist (trametinib dimethyl sulfoxide)
    Low-Grade Glioma$NVS NOVARTIS AG43 cat
  • Marketed
    dabrafenib mesylate ODT
    Tafinlar (dabrafenib mesylate)
    Low-Grade Glioma$NVS NOVARTIS AG40 cat
  • Marketed
    trastuzumab emtansine
    Kadcyla (trastuzumab emtansine)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… Genentech Inc14 cat
  • Marketed
    CINACALCET HYDROCHLORIDE
    CINACALCET HYDROCHLORIDE
    Hypercalcemia Slate Run Pharmaceuticals LLC6 cat
  • Marketed
    fedratinib
    Inrebic (fedratinib)
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Bristol-Myers Squibb Co7 cat
  • Marketed
    pacritinib
    Vonjo (pacritinib)
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Sobi Inc6 cat
  • Marketed
    momelotinib dihydrochloride
    Ojjaara (momelotinib dihydrochloride)
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) GlaxoSmithKline LLC4 cat
  • Marketed
    polatuzumab vedotin
    Polivy (polatuzumab vedotin-piiq)
    Diffuse Large B-Cell Lymphoma Genentech Inc4 cat
  • Marketed
    OXALIPLATIN
    OXALIPLATIN
    Colon Cancer Ingenus Pharmaceuticals LLC4 cat
  • Marketed
    GEMCITABINE HYDROCHLORIDE
    GEMCITABINE HYDROCHLORIDE
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$JNJ JOHNSON & JOHNSON3 cat
  • Marketed
    omeprazole DR
    Prilosec (omeprazole)
    Multiple Endocrine Adenomas Covis Pharmaceuticals Inc (Inactive)38 cat
  • Marketed
    Doxil
    Doxil (doxorubicin hydrochloride)
    Kaposi Sarcoma$BAX BAXTER INTERNATIONAL INC29 cat
  • Marketed
    LEUCOVORIN CALCIUM
    LEUCOVORIN CALCIUM
    Metastatic Colorectal Cancer Avyxa Pharma LLC6 cat
  • Marketed
    EVEROLIMUS
    EVEROLIMUS
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Novugen Pharma (Malaysia) Sdn Bhd6 cat
  • Marketed
    apalutamide
    Erleada (apalutamide [INN])
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON15 cat
  • Marketed
    teclistamab
    Tecvayli (teclistamab-cqyv)
    Refractory Multiple Myeloma Janssen Biotech Inc11 cat
  • Marketed
    talquetamab
    Talvey (talquetamab-tgvs)
    Refractory Multiple Myeloma$JNJ JOHNSON & JOHNSON8 cat
  • Marketed
    lurbinectedin
    Zepzelca (lurbinectedin)
    Ewing Sarcoma$JAZZ Jazz Pharmaceuticals plc6 cat